Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 98,169 | 52,557 | 50,754 | 70,582 | 51,217 |
| Cost of Goods | 29,557 | 10,940 | 9,943 | 9,415 | 9,076 |
| Gross Profit | 68,612 | 41,617 | 40,811 | 61,167 | 42,141 |
| Operating Expenses | 49,023 | 53,706 | 53,885 | 54,453 | 56,468 |
| Operating Income | 20,146 | -11,149 | -12,131 | 7,129 | -14,251 |
| Interest Expense | 3,450 | 3,567 | 3,627 | 3,784 | 3,068 |
| Other Income | -130 | -71 | -15,705 | 50 | 386 |
| Pre-tax Income | 16,566 | -14,787 | -31,463 | 3,395 | -16,933 |
| Income Tax | 38 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 16,528 | -14,994 | -31,463 | 3,395 | -16,933 |
| Net Income | $16,528 | $-14,994 | $-31,463 | $3,395 | $-16,933 |
| EPS Basic Total Ops | 0.41 | -0.39 | -0.79 | 0.09 | -0.43 |
| EPS Basic Continuous Ops | 0.41 | -0.38 | -0.79 | 0.09 | -0.43 |
| EPS Diluted Total Ops | 0.40 | -0.38 | -0.79 | 0.08 | -0.43 |
| EPS Diluted Continuous Ops | 0.40 | -0.38 | -0.79 | 0.08 | -0.43 |
| EBITDA(a) | $23,097 | $-8,201 | $-9,199 | $9,366 | $-12,335 |